Related Experiment Video
Updated: Apr 13, 2026

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies
Forum Kamdar1, Andre Klaassen Kamdar1, Naoko Koyano-Nakagawa1
1Cardiovascular Division and Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota.
Insights
Patient-specific induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a powerful "disease in a dish" model. These hiPSC-CMs help unravel the complex molecular mechanisms underlying inherited cardiomyopathies.
Area of Science:
- Cardiovascular Medicine
- Stem Cell Biology
- Genetics
Background:
- Inherited cardiomyopathies are genetically defined cardiovascular diseases.
- Understanding their molecular mechanisms is crucial but challenging.
- Traditional models have limitations in recapitulating human disease.
Purpose of the Study:
- To review the application of patient-specific human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) for in vitro modeling of inherited cardiomyopathies.
- To highlight the potential of hiPSC-CMs as a "disease in a dish" model.
- To provide an overview of current research in this field.
Main Methods:
- Generation of patient-specific hiPSC-derived cardiomyocytes (CMs).
- Maintenance of hiPSC-CMs in cell culture.
- Characterization of disease phenotypes in vitro using hiPSC-CMs.
Main Results:
- hiPSC-derived CMs retain the patient's genetic blueprint.
- These cells recapitulate the phenotypic characteristics of inherited cardiomyopathies in vitro.
- This technology enables the study of disease mechanisms in a patient-specific manner.
Conclusions:
- Patient-specific hiPSC-derived CMs are a valuable tool for studying inherited cardiomyopathies.
- This in vitro modeling approach advances our understanding of cardiovascular disease mechanisms.
- hiPSC-CMs hold promise for future therapeutic development.
Abstract:
Inherited cardiomyopathies, including hypertrophic cardiomyopathy, dilated cardiomyopathies, arrythmogenic right ventricular cardiomyopathy, and other inherited forms of heart failure, represent a unique set of genetically defined cardiovascular disease processes. Unraveling the molecular mechanisms of these deadly forms of human heart disease has been challenging, but recent groundbreaking scientific advances in stem cell technology have allowed for the generation of patient-specific human inducible stem cell (hiPSC)-derived cardiomyocytes (CMs). hiPSC-derived CMs retain the genetic blueprint of the patient, they can be maintained in culture, and they recapitulate the phenotypic characteristics of the disease in vitro, thus serving as a disease in a dish. This review provides an overview of in vitro modeling of inherited cardiomyopathies with the use of patient-specific hiPSC-derived CMs.
More Related Videos
08:37Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
05:06Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020